Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Solara Active Pharma Sciences's
Operating Income
for the
three
months ended in Mar. 2026 was ₹316 Mil. Solara Active Pharma Sciences's Interest Expense for the
three
months ended in Mar. 2026 was ₹-276 Mil.
Solara Active Pharma Sciences's interest coverage for the quarter that ended in Mar. 2026 was 1.15.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Solara Active Pharma Sciences's Interest Coverage or its related term are showing as below:
NSE:SOLARAPP1'
s Interest Coverage Range Over the Past 10 Years
Min: 0.4 Med: 2.05 Max: 3.52
Current: 0.92
NSE:SOLARAPP1's Interest Coverage is ranked worse than 93.28% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs NSE:SOLARAPP1: 0.92
Solara Active Pharma Sciences (NSE:SOLARAPP1) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Solara Active Pharma Sciences Interest Coverage Related Terms
Solara Active Pharma Sciences Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Solara Active Pharma Sciences Interest Coverage Chart
NSE:SOLARAPP1 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solara Active Pharma Sciences Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Solara Active Pharma Sciences's Interest Coverage falls into.
Solara Active Pharma Sciences Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a Interest Coverage of 1.15 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Solara Active Pharma Sciences and its competitors. This is 44% below median its historical median of 2.05. Over the past decade, Solara Active Pharma Sciences' Interest Coverage has ranged from 0.40 to 3.52. According to the industry distribution chart, Solara Active Pharma Sciences ranks #639 out of 685 companies in the Drug Manufacturers industry, placing it in the top 93.3%.
Is Solara Active Pharma Sciences' Interest Coverage too high?
Solara Active Pharma Sciences' current Interest Coverage of 1.15 is 44% below median its 10-year median of 2.05. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 3.52. The Drug Manufacturers industry median Interest Coverage is 12.75. Solara Active Pharma Sciences' value of 1.15 is 91% below this industry median. Based on the distribution chart, Solara Active Pharma Sciences ranks #639 out of 685 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Solara Active Pharma Sciences has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Solara Active Pharma Sciences' Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Solara Active Pharma Sciences ranks #639 out of 685 companies for Interest Coverage. This places Solara Active Pharma Sciences in the lower half of its industry. The industry median Interest Coverage is 12.75. Solara Active Pharma Sciences' value of 1.15 is 91% below this benchmark. Historically, Solara Active Pharma Sciences' own Interest Coverage has ranged from 0.40 to 3.52 over the past decade. While the company's 10-year median is 2.05 vs. the industry median of 12.75, Solara Active Pharma Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Solara Active Pharma Sciences's current Interest Coverage of 1.15 is 91% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Solara Active Pharma Sciences and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solara Active Pharma Sciences's current Interest Coverage is 1.15, which is 44% below median its own 10-year median of 2.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solara Active Pharma Sciences stock overvalued right now?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a current Interest Coverage of 1.15. The stock's GF Value™ is ₹261.61, compared to a current price of ₹267.45 — trading 2.2% above its estimated fair value. The current Interest Coverage is 1.15, which is 44% below median its 10-year median of 2.05 and 91% below the Drug Manufacturers industry median of 12.75. Solara Active Pharma Sciences' overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Solara Active Pharma Sciences (NSE:SOLARAPP1), the current Interest Coverage is 1.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Solara Active Pharma Sciences (NSE:SOLARAPP1) Overvalued in 2026?
Based on GuruFocus' analysis, Solara Active Pharma Sciences stock appears to be overvalued.
The current stock price of ₹267.45 is trading 2.2% above its estimated GF Value™ of ₹261.61.
Key valuation signals for NSE:SOLARAPP1:
Interest Coverage: 1.15 (44% below median its 10-year median of 2.05)
GF Value™: ₹261.61 vs. price of ₹267.45 (2.2% above fair value)
Industry Position: 91% below the Drug Manufacturers median (#639 of 685)
No single metric tells the full story. See the NSE:SOLARAPP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Solara Active Pharma Sciences Business Description
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
68GF Score
Get the complete analysis for NSE:SOLARAPP1
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SOLARAPP1 has been successfully added to your 
